| Feb 13, 2026 |
Feb 18, 2026 |
McAlevey Michael R
|
EVP & Chief Legal & Admin Off. |
Sell |
17.5
|
-5,000
|
-31.27%
|
✗
|
$2.7M |
| Feb 10, 2026 |
Feb 12, 2026 |
Wyatt Christopher F.
|
SVP & Controller |
Sell |
17.5
|
-1,684
|
-3.66%
|
✗
|
$2.5M |
| Feb 10, 2026 |
Feb 12, 2026 |
Rossitto Erica
|
SVP & Chief Nurse Executive |
Sell |
95.0
|
+1,258
|
13.75%
|
✗
|
$209.9K |
| Feb 10, 2026 |
Feb 12, 2026 |
McAlevey Michael R
|
EVP & Chief Legal & Admin Off. |
Sell |
100.0
|
+5,366
|
95.41%
|
✗
|
$1.5M |
| Feb 10, 2026 |
Feb 12, 2026 |
Marks Mike A
|
CFO |
Sell |
90.0
|
+3,336
|
4.78%
|
✗
|
$848.5K |
| Feb 10, 2026 |
Feb 12, 2026 |
HAZEN SAMUEL N
|
CEO |
Sell |
90.0
|
+33,611
|
2.49%
|
✗
|
$10.7M |
| Feb 10, 2026 |
Feb 12, 2026 |
Foster Jon M
|
COO |
Sell |
95.0
|
+9,808
|
5.31%
|
✗
|
$3M |
| Feb 10, 2026 |
Feb 12, 2026 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Sell |
95.0
|
+6,127
|
9.96%
|
✗
|
$1.8M |
| Feb 10, 2026 |
Feb 12, 2026 |
Berres Jennifer
|
SVP & Chief Human Res. Officer |
Sell |
16.3
|
-3,419
|
-22.18%
|
✗
|
$5.4M |
| Feb 6, 2026 |
Feb 10, 2026 |
FRIST THOMAS F JR
|
10% Owner |
Neutral |
52.5
|
-72,047
|
-0.10%
|
✗
|
- |
| Feb 6, 2026 |
Feb 10, 2026 |
Frist William R
|
Director |
Neutral |
52.5
|
-72,047
|
-0.10%
|
✗
|
- |
| Feb 6, 2026 |
Feb 10, 2026 |
FRIST THOMAS F III
|
Director |
Neutral |
52.5
|
-72,047
|
-0.10%
|
✗
|
- |
| Feb 6, 2026 |
Feb 10, 2026 |
Elcan Patricia F
|
10% Owner |
Neutral |
52.5
|
-72,047
|
-0.10%
|
✗
|
- |
| Feb 6, 2026 |
Feb 10, 2026 |
HERCULES HOLDING II
|
10% Owner |
Neutral |
27.5
|
-36,629,188
|
-53.15%
|
✗
|
- |
| Feb 6, 2026 |
Feb 10, 2026 |
Frisco Holding II
|
10% Owner |
Neutral |
52.5
|
-72,047
|
-0.20%
|
✗
|
- |
| Feb 5, 2026 |
Feb 9, 2026 |
Wyatt Christopher F.
|
SVP & Controller |
Sell |
17.5
|
-5,674
|
-10.97%
|
✗
|
$2.9M |
| Feb 5, 2026 |
Feb 9, 2026 |
Foster Jon M
|
COO |
Sell |
16.3
|
-16,076
|
-8.01%
|
✗
|
$8.3M |
|
Feb 6, 2026 |
Rossitto Erica
|
SVP & Chief Nurse Executive |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2026 |
Feb 5, 2026 |
HAZEN SAMUEL N
|
CEO |
Sell |
15.0
|
-42,877
|
-3.08%
|
✗
|
$21.5M |
| Feb 3, 2026 |
Feb 5, 2026 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Sell |
20.0
|
-5,550
|
-17.62%
|
✗
|
$747.1K |
| Jan 29, 2026 |
Feb 2, 2026 |
Wyatt Christopher F.
|
SVP & Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Feb 2, 2026 |
McAlevey Michael R
|
EVP & Chief Legal & Admin Off. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Feb 2, 2026 |
Marks Mike A
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 30, 2026 |
Feb 2, 2026 |
HAZEN SAMUEL N
|
CEO |
Sell |
15.0
|
-41,483
|
-2.89%
|
✗
|
$20.3M |
| Jan 29, 2026 |
Feb 2, 2026 |
Foster Jon M
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Feb 2, 2026 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Feb 2, 2026 |
Berres Jennifer
|
SVP & Chief Human Res. Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 14, 2025 |
Nov 18, 2025 |
HAZEN SAMUEL N
|
CEO |
Neutral |
27.5
|
-14,830
|
-1.09%
|
✗
|
- |
| Nov 3, 2025 |
Nov 5, 2025 |
McAlevey Michael R
|
EVP & Chief Legal & Admin Off. |
Sell |
16.3
|
-13,170
|
-70.08%
|
✗
|
$6.1M |
| Nov 3, 2025 |
Nov 5, 2025 |
Marks Mike A
|
CFO |
Neutral |
45.0
|
-165
|
-0.24%
|
✗
|
- |
| Oct 31, 2025 |
Nov 4, 2025 |
HAZEN SAMUEL N
|
CEO |
Sell |
15.0
|
-28,173
|
-2.02%
|
✗
|
$13M |
| Sep 4, 2025 |
Sep 8, 2025 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Sell |
20.0
|
-10,920
|
-14.04%
|
✓
|
$4.5M |
| Jul 29, 2025 |
Jul 31, 2025 |
CHIDSEY JOHN
|
Director |
Neutral |
90.0
|
+496
|
1771.43%
|
✗
|
- |
|
Jul 18, 2025 |
CHIDSEY JOHN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
HAZEN SAMUEL N
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Foster Jon M
|
COO |
Sell |
16.3
|
-15,698
|
-8.39%
|
✗
|
$5.8M |
| May 6, 2025 |
May 8, 2025 |
Marks Mike A
|
CFO |
Neutral |
45.0
|
-288
|
-0.41%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
Frist William R
|
Director |
Buy |
57.5
|
+11,530
|
0.02%
|
✗
|
$3.6M |
| Apr 29, 2025 |
May 1, 2025 |
FRIST THOMAS F III
|
Director |
Neutral |
47.5
|
+1,320
|
0.00%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
Smith Andrea B
|
Director |
Neutral |
90.0
|
+645
|
17.95%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
Riley Wayne Joseph
|
Director |
Neutral |
82.5
|
+645
|
4.65%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
MICHELSON MICHAEL W
|
Director |
Neutral |
90.0
|
+1,173
|
11.19%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
Johnston Hugh F
|
Director |
Neutral |
90.0
|
+1,026
|
38.86%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
DEPARLE NANCY ANN
|
Director |
Neutral |
82.5
|
+645
|
3.11%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
Dennis Robert J
|
Director |
Neutral |
82.5
|
+1,026
|
4.01%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Wyatt Christopher F.
|
SVP & Controller |
Sell |
82.5
|
+618
|
1.53%
|
✗
|
$73.1K |
| Feb 13, 2025 |
Feb 18, 2025 |
Mosier Sammie S
|
SVP & Chief Nurse Executive |
Sell |
90.0
|
+618
|
5.89%
|
✗
|
$73.1K |
| Feb 13, 2025 |
Feb 18, 2025 |
McAlevey Michael R
|
EVP & Chief Legal & Admin Off. |
Sell |
95.0
|
+1,586
|
39.28%
|
✗
|
$170.9K |
| Feb 13, 2025 |
Feb 18, 2025 |
Marks Mike A
|
CFO |
Sell |
72.5
|
+466
|
0.67%
|
✗
|
$55.4K |
| Feb 13, 2025 |
Feb 18, 2025 |
HAZEN SAMUEL N
|
CEO |
Sell |
77.5
|
+8,476
|
0.64%
|
✗
|
$1.5M |
| Feb 13, 2025 |
Feb 18, 2025 |
Foster Jon M
|
COO |
Sell |
82.5
|
+2,066
|
1.25%
|
✗
|
$220.2K |
| Feb 13, 2025 |
Feb 18, 2025 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Sell |
90.0
|
+1,747
|
5.89%
|
✗
|
$187.7K |
| Feb 13, 2025 |
Feb 18, 2025 |
Berres Jennifer
|
SVP & Chief Human Res. Officer |
Sell |
17.5
|
-8,352
|
-35.15%
|
✗
|
$3.2M |
| Feb 7, 2025 |
Feb 11, 2025 |
Berres Jennifer
|
SVP & Chief Human Res. Officer |
Sell |
17.5
|
-6,747
|
-22.11%
|
✗
|
$2.2M |
| Feb 3, 2025 |
Feb 5, 2025 |
Mosier Sammie S
|
SVP & Chief Nurse Executive |
Sell |
43.8
|
-41
|
-0.39%
|
✗
|
$13.7K |
| Jan 28, 2025 |
Jan 30, 2025 |
Wyatt Christopher F.
|
SVP & Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2025 |
Jan 30, 2025 |
Mosier Sammie S
|
SVP & Chief Nurse Executive |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2025 |
Jan 30, 2025 |
McAlevey Michael R
|
EVP & Chief Legal & Admin Off. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2025 |
Jan 30, 2025 |
Marks Mike A
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2025 |
Jan 30, 2025 |
HAZEN SAMUEL N
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2025 |
Jan 30, 2025 |
Foster Jon M
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2025 |
Jan 30, 2025 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 28, 2025 |
Jan 30, 2025 |
Berres Jennifer
|
SVP & Chief Human Res. Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 14, 2024 |
Nov 18, 2024 |
Whalen Kathleen M
|
SVP & Chief Ethics Officer |
Sell |
20.0
|
-1,474
|
-13.49%
|
✗
|
$527.7K |
| May 15, 2024 |
Nov 18, 2024 |
Foster Jon M
|
COO |
Sell |
16.3
|
-20,902
|
-8.17%
|
✗
|
$7.2M |
| Nov 12, 2024 |
Nov 14, 2024 |
Billington Phillip G
|
SVP-Internal Audit Services |
Sell |
17.5
|
-8,000
|
-13.18%
|
✗
|
$2.8M |
| Nov 12, 2024 |
Nov 14, 2024 |
Akdamar Erol R
|
President |
Sell |
17.5
|
-13,157
|
-9.36%
|
✗
|
$4.6M |
| Nov 11, 2024 |
Nov 13, 2024 |
Whalen Kathleen M
|
SVP & Chief Ethics Officer |
Sell |
17.5
|
-3,236
|
-22.85%
|
✗
|
$1.2M |
| Oct 30, 2024 |
Nov 1, 2024 |
Elcan Patricia F
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 10, 2024 |
Sep 12, 2024 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Sell |
3.8
|
-22,080
|
-42.66%
|
✓
|
$8.5M |
| Aug 8, 2024 |
Aug 12, 2024 |
Marks Mike A
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 6, 2024 |
Aug 8, 2024 |
HAZEN SAMUEL N
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 5, 2024 |
Aug 7, 2024 |
Sowell Joseph A III
|
SVP; Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 31, 2024 |
Aug 2, 2024 |
McManus Timothy M
|
President |
Sell |
17.5
|
-3,919
|
-12.67%
|
✗
|
$1.4M |
| Jul 29, 2024 |
Jul 31, 2024 |
Whalen Kathleen M
|
SVP & Chief Ethics Officer |
Sell |
17.5
|
-10,144
|
-51.76%
|
✗
|
$3.7M |
| Jul 29, 2024 |
Jul 31, 2024 |
Reiner Deborah M
|
SVP - Mktg. & Communications |
Sell |
17.5
|
-3,314
|
-48.56%
|
✗
|
$1.2M |
| Jul 25, 2024 |
Jul 29, 2024 |
Wyatt Christopher F.
|
SVP & Controller |
Sell |
17.5
|
-9,278
|
-18.66%
|
✗
|
$3.3M |
| Jul 25, 2024 |
Jul 29, 2024 |
Torres Kathryn A.
|
SVP-Payer Contracting & Align. |
Sell |
20.0
|
-1,857
|
-9.47%
|
✗
|
$659.3K |
| May 16, 2024 |
May 20, 2024 |
Whalen Kathleen M
|
SVP & Chief Ethics Officer |
Sell |
17.5
|
-6,065
|
-22.60%
|
✗
|
$2M |
| May 15, 2024 |
May 17, 2024 |
Torres Kathryn A.
|
SVP-Payer Contracting & Align. |
Sell |
20.0
|
-1,863
|
-8.68%
|
✗
|
$607.7K |
| May 15, 2024 |
May 17, 2024 |
Sowell Joseph A III
|
SVP; Chief Development Officer |
Sell |
17.5
|
-9,908
|
-14.97%
|
✗
|
$3.2M |
| May 15, 2024 |
May 17, 2024 |
Foster Jon M
|
COO |
Sell |
16.3
|
-21,258
|
-11.15%
|
✗
|
$7M |
| May 9, 2024 |
May 13, 2024 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Sell |
17.5
|
-6,311
|
-17.56%
|
✗
|
$2M |
| May 9, 2024 |
May 13, 2024 |
Cohen Jeffrey E.
|
SVP-Government Relations |
Sell |
20.0
|
-1,650
|
-24.14%
|
✗
|
$516.5K |
| May 9, 2024 |
May 13, 2024 |
Akdamar Erol R
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 6, 2024 |
May 8, 2024 |
Cuffe Michael S.
|
EVP and Chief Clinical Officer |
Sell |
17.5
|
-18,449
|
-14.31%
|
✗
|
$4.4M |
| May 2, 2024 |
May 6, 2024 |
Torres Kathryn A.
|
SVP-Payer Contracting & Align. |
Sell |
20.0
|
-1,863
|
-7.98%
|
✗
|
$581.3K |
| Apr 29, 2024 |
May 1, 2024 |
FRIST THOMAS F III
|
Director |
Neutral |
47.5
|
+1,284
|
0.00%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
Frist William R
|
Director |
Neutral |
47.5
|
+963
|
0.00%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
Smith Andrea B
|
Director |
Neutral |
90.0
|
+610
|
20.44%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
Riley Wayne Joseph
|
Director |
Neutral |
82.5
|
+610
|
4.60%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
MICHELSON MICHAEL W
|
Director |
Neutral |
90.0
|
+1,091
|
11.62%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
Johnston Hugh F
|
Director |
Neutral |
90.0
|
+610
|
30.05%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
DEPARLE NANCY ANN
|
Director |
Neutral |
82.5
|
+610
|
3.03%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
Dennis Robert J
|
Director |
Neutral |
82.5
|
+963
|
3.91%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
CROFTON MEG
|
Director |
Neutral |
90.0
|
+610
|
10.66%
|
✗
|
- |
| Apr 29, 2024 |
May 1, 2024 |
McAlevey Michael R
|
EVP - Chief Legal & Admin Off |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2024 |
May 1, 2024 |
Marks Mike A
|
CFO |
Neutral |
37.5
|
-566
|
-0.81%
|
✗
|
- |
| Mar 18, 2024 |
Mar 20, 2024 |
Wasserman Chad J
|
SVP and CIO |
Sell |
7.5
|
-2,444
|
-60.79%
|
✓
|
$800.5K |
| Feb 16, 2024 |
Feb 21, 2024 |
Wyatt Christopher F.
|
SVP & Controller |
Sell |
92.5
|
+3,044
|
8.14%
|
✗
|
$609.7K |